TARGETING THE M2-TUMOR ASSOCIATED MACROPHAGE FOR CANCER THERAPY
- 专利权人:
- The Johns Hopkins University
- 发明人:
- Kenneth Pienta
- 申请号：
- US15827186
- 公开号：
- US20180264130A1
- 申请日:
- 2017.11.30
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要：
- The present invention features methods of directly targeting specific cell surface receptors on the M2 macrophage for antibody or nanoparticle directed therapy.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- TARGETING THE M2-TUMOR ASSOCIATED MACROPHAGE FOR CANCER THERAPY
- Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types
- TREATMENT OF CANCER USING ANTIBODIES COMBINING WITH SURFACE GRP78
- Non-self T cell epitopes fused to antibodies recognizing tumor-specific cell surface receptors and uses thereof
- CANCER TREATMENT USING ANTIBODIES THAT BIND CELL SURFACE GRP78
